Selected research
Industry Research
Third-Party Drug Testing Administration service Industry Research Report 2026
Market perspective
The global Third-Party Drug Testing Administration service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Third-Party Drug Testing Administration service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Third-Party Drug Testing Administration service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Third-Party Drug Testing Administration service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Third-Party Drug Testing Administration service include Lobdock, Info Cubic, Procom Testing, Midway, National Drug Screening, CO-OP Drug Testing, ADVANTAGECARE, CannAmm and Medway, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Third-Party Drug Testing Administration service market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Third-Party Drug Testing Administration service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Third-Party Drug Testing Administration service Market by Company
Lobdock
Info Cubic
Procom Testing
Midway
National Drug Screening
CO-OP Drug Testing
ADVANTAGECARE
CannAmm
Medway
AMDT
WorkPlace Health
Global Verification Network
Mobile Medical Corporation
DRUG TESTING CORPORATION
Origin
Third-Party Drug Testing Administration service Segment by Type
Pre-Employment Drug Testing
Reasonable Suspicion Drug Testing
Random Drug Testing
Return-to-Duty Drug Testing
Post-Accident Drug Testing
Others
Third-Party Drug Testing Administration service Segment by Application
SMEs
Large Enterprise
Third-Party Drug Testing Administration service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Third-Party Drug Testing Administration service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Third-Party Drug Testing Administration service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Third-Party Drug Testing Administration service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Third-Party Drug Testing Administration service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pre-Employment Drug Testing
- Reasonable Suspicion Drug Testing
- Random Drug Testing
- Return-to-Duty Drug Testing
- Post-Accident Drug Testing
- Others
Applications
- SMEs
- Large Enterprise
Companies covered
- Lobdock
- Info Cubic
- Procom Testing
- Midway
- National Drug Screening
- CO-OP Drug Testing
- ADVANTAGECARE
- CannAmm
- Medway
- AMDT
- WorkPlace Health
- Global Verification Network
- Mobile Medical Corporation
- DRUG TESTING CORPORATION
- Origin
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Third-Party Drug Testing Administration service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Pre-Employment Drug Testing
- 2.2.3 Reasonable Suspicion Drug Testing
- 2.2.4 Random Drug Testing
- 2.2.5 Return-to-Duty Drug Testing
- 2.2.6 Post-Accident Drug Testing
- 2.2.7 Others
- 2.3 Third-Party Drug Testing Administration service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 SMEs
- 2.3.3 Large Enterprise
- 2.4 Assumptions and Limitations
3 Third-Party Drug Testing Administration service Breakdown Data by Type
- 3.1 Global Third-Party Drug Testing Administration service Historic Market Size by Type (2021-2026)
- 3.2 Global Third-Party Drug Testing Administration service Forecasted Market Size by Type (2027-2032)
4 Third-Party Drug Testing Administration service Breakdown Data by Application
- 4.1 Global Third-Party Drug Testing Administration service Historic Market Size by Application (2021-2026)
- 4.2 Global Third-Party Drug Testing Administration service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Third-Party Drug Testing Administration service Market Perspective (2021-2032)
- 5.2 Global Third-Party Drug Testing Administration service Growth Trends by Region
- 5.2.1 Global Third-Party Drug Testing Administration service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Third-Party Drug Testing Administration service Historic Market Size by Region (2021-2026)
- 5.2.3 Third-Party Drug Testing Administration service Forecasted Market Size by Region (2027-2032)
- 5.3 Third-Party Drug Testing Administration service Market Dynamics
- 5.3.1 Third-Party Drug Testing Administration service Industry Trends
- 5.3.2 Third-Party Drug Testing Administration service Market Drivers
- 5.3.3 Third-Party Drug Testing Administration service Market Challenges
- 5.3.4 Third-Party Drug Testing Administration service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Third-Party Drug Testing Administration service Players by Revenue
- 6.1.1 Global Top Third-Party Drug Testing Administration service Players by Revenue (2021-2026)
- 6.1.2 Global Third-Party Drug Testing Administration service Revenue Market Share by Players (2021-2026)
- 6.2 Global Third-Party Drug Testing Administration service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Third-Party Drug Testing Administration service Head Office and Area Served
- 6.4 Global Third-Party Drug Testing Administration service Players, Product Type & Application
- 6.5 Global Third-Party Drug Testing Administration service Manufacturers Established Date
- 6.6 Global Third-Party Drug Testing Administration service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Third-Party Drug Testing Administration service Market Size (2021-2032)
- 7.2 North America Third-Party Drug Testing Administration service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
- 7.4 North America Third-Party Drug Testing Administration service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Third-Party Drug Testing Administration service Market Size (2021-2032)
- 8.2 Europe Third-Party Drug Testing Administration service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
- 8.4 Europe Third-Party Drug Testing Administration service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Third-Party Drug Testing Administration service Market Size (2021-2032)
- 9.2 Asia-Pacific Third-Party Drug Testing Administration service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Third-Party Drug Testing Administration service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Third-Party Drug Testing Administration service Market Size (2021-2032)
- 10.2 South America Third-Party Drug Testing Administration service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
- 10.4 South America Third-Party Drug Testing Administration service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Third-Party Drug Testing Administration service Market Size (2021-2032)
- 11.2 Middle East & Africa Third-Party Drug Testing Administration service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Third-Party Drug Testing Administration service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Lobdock
- 12.1.1 Lobdock Company Information
- 12.1.2 Lobdock Business Overview
- 12.1.3 Lobdock Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.1.4 Lobdock Third-Party Drug Testing Administration service Product Portfolio
- 12.1.5 Lobdock Recent Developments
- 12.2 Info Cubic
- 12.2.1 Info Cubic Company Information
- 12.2.2 Info Cubic Business Overview
- 12.2.3 Info Cubic Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.2.4 Info Cubic Third-Party Drug Testing Administration service Product Portfolio
- 12.2.5 Info Cubic Recent Developments
- 12.3 Procom Testing
- 12.3.1 Procom Testing Company Information
- 12.3.2 Procom Testing Business Overview
- 12.3.3 Procom Testing Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.3.4 Procom Testing Third-Party Drug Testing Administration service Product Portfolio
- 12.3.5 Procom Testing Recent Developments
- 12.4 Midway
- 12.4.1 Midway Company Information
- 12.4.2 Midway Business Overview
- 12.4.3 Midway Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.4.4 Midway Third-Party Drug Testing Administration service Product Portfolio
- 12.4.5 Midway Recent Developments
- 12.5 National Drug Screening
- 12.5.1 National Drug Screening Company Information
- 12.5.2 National Drug Screening Business Overview
- 12.5.3 National Drug Screening Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.5.4 National Drug Screening Third-Party Drug Testing Administration service Product Portfolio
- 12.5.5 National Drug Screening Recent Developments
- 12.6 CO-OP Drug Testing
- 12.6.1 CO-OP Drug Testing Company Information
- 12.6.2 CO-OP Drug Testing Business Overview
- 12.6.3 CO-OP Drug Testing Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.6.4 CO-OP Drug Testing Third-Party Drug Testing Administration service Product Portfolio
- 12.6.5 CO-OP Drug Testing Recent Developments
- 12.7 ADVANTAGECARE
- 12.7.1 ADVANTAGECARE Company Information
- 12.7.2 ADVANTAGECARE Business Overview
- 12.7.3 ADVANTAGECARE Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.7.4 ADVANTAGECARE Third-Party Drug Testing Administration service Product Portfolio
- 12.7.5 ADVANTAGECARE Recent Developments
- 12.8 CannAmm
- 12.8.1 CannAmm Company Information
- 12.8.2 CannAmm Business Overview
- 12.8.3 CannAmm Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.8.4 CannAmm Third-Party Drug Testing Administration service Product Portfolio
- 12.8.5 CannAmm Recent Developments
- 12.9 Medway
- 12.9.1 Medway Company Information
- 12.9.2 Medway Business Overview
- 12.9.3 Medway Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.9.4 Medway Third-Party Drug Testing Administration service Product Portfolio
- 12.9.5 Medway Recent Developments
- 12.10 AMDT
- 12.10.1 AMDT Company Information
- 12.10.2 AMDT Business Overview
- 12.10.3 AMDT Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.10.4 AMDT Third-Party Drug Testing Administration service Product Portfolio
- 12.10.5 AMDT Recent Developments
- 12.11 WorkPlace Health
- 12.11.1 WorkPlace Health Company Information
- 12.11.2 WorkPlace Health Business Overview
- 12.11.3 WorkPlace Health Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.11.4 WorkPlace Health Third-Party Drug Testing Administration service Product Portfolio
- 12.11.5 WorkPlace Health Recent Developments
- 12.12 Global Verification Network
- 12.12.1 Global Verification Network Company Information
- 12.12.2 Global Verification Network Business Overview
- 12.12.3 Global Verification Network Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.12.4 Global Verification Network Third-Party Drug Testing Administration service Product Portfolio
- 12.12.5 Global Verification Network Recent Developments
- 12.13 Mobile Medical Corporation
- 12.13.1 Mobile Medical Corporation Company Information
- 12.13.2 Mobile Medical Corporation Business Overview
- 12.13.3 Mobile Medical Corporation Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.13.4 Mobile Medical Corporation Third-Party Drug Testing Administration service Product Portfolio
- 12.13.5 Mobile Medical Corporation Recent Developments
- 12.14 DRUG TESTING CORPORATION
- 12.14.1 DRUG TESTING CORPORATION Company Information
- 12.14.2 DRUG TESTING CORPORATION Business Overview
- 12.14.3 DRUG TESTING CORPORATION Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.14.4 DRUG TESTING CORPORATION Third-Party Drug Testing Administration service Product Portfolio
- 12.14.5 DRUG TESTING CORPORATION Recent Developments
- 12.15 Origin
- 12.15.1 Origin Company Information
- 12.15.2 Origin Business Overview
- 12.15.3 Origin Revenue in Third-Party Drug Testing Administration service Business (2021-2026)
- 12.15.4 Origin Third-Party Drug Testing Administration service Product Portfolio
- 12.15.5 Origin Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst